Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancer
Open Access
- 9 June 2016
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 115 (3), 339-345
- https://doi.org/10.1038/bjc.2016.178
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplificationBreast Cancer Research and Treatment, 2012
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast CancerThe New England Journal of Medicine, 2012
- Evaluation of eIF4E Expression in an Osteosarcoma-Specific Tissue MicroarrayJournal of Pediatric Hematology/Oncology, 2011
- The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor SignalingScience, 2011
- Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, a Biomarker with Prognostic Specificity for Luminal B-Type Breast CancerClinical Cancer Research, 2011
- Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancerBreast Cancer Research and Treatment, 2010
- Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activityBritish Journal of Cancer, 2009
- Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancerJournal of Clinical Pathology, 2006
- eIF4E is a central node of an RNA regulon that governs cellular proliferationThe Journal of cell biology, 2006
- High eIF4E, VEGF, and Microvessel Density in Stage I to III Breast CancerAnnals of Surgery, 2006